Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough
- 29 April 2004
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 19 (10) , 1105-1110
- https://doi.org/10.1111/j.1365-2036.2004.01949.x
Abstract
Twice-daily dosing is increasingly used to improve gastric acid control, although not all proton-pump inhibitors are more effective when doses are split. Standard dose esomeprazole provides better gastric acid control than other standard dose proton-pump inhibitors. To compare the effect of standard dose esomeprazole (1 x 40 mg) with 20 mg b.d. on gastric acidity. Thirteen healthy subjects participated in this crossover study, receiving esomeprazole 2 x 20 mg and 1 x 40 mg for 7 days in random order with a washout period of at least 7 days. Gastric 24-h pH was measured on days 1, 2 and 6. Median gastric 24-h pH was higher during 2 x 20 mg esomeprazole on day 2 (P < 0.01), no differences were detected on day 6. Night-time gastric acid suppression was significantly improved by 2 x 20 mg esomeprazole on all study days (P < 0.05). Nocturnal acid breakthrough was observed on all study days in subjects receiving 1 x 40 mg, but in only 85% (first night), 64% (second night), and 45% of subjects (sixth night) with 2 x 20 mg (P < 0.05). Splitting the esomeprazole dose improves initial acid suppression, this effect starts at the first night. Maximal benefit is achieved on day 2, while the effect on night-time acid control is detectable during the entire first week of treatment.Keywords
This publication has 30 references indexed in Scilit:
- Biochemical reversal of proton pump inhibition in vivoGastroenterology, 2003
- Esomeprazole 40 Mg provides more effective acid control than standard doses of all other proton pump inhibitorsGastroenterology, 2001
- Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of OmeprazoleClinical Pharmacokinetics, 2001
- Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialAlimentary Pharmacology & Therapeutics, 2000
- Gastric acidity and acid breakthrough with twice‐daily omeprazole or lansoprazoleAlimentary Pharmacology & Therapeutics, 2000
- MEDICAL THERAPY: Management of the Refractory PatientGastroenterology Clinics of North America, 1999
- Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazoleGut, 1999
- Experimental study of acid burden and acute oesophagitisBritish Journal of Surgery, 1998
- Comparison of pantoprazole 20 MG twice daily with 40 MG once daily on intragastric PH in healthy volunteersGastroenterology, 1998
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992